Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 392

1.

Renal glucose metabolism in normal physiological conditions and in diabetes.

Alsahli M, Gerich JE.

Diabetes Res Clin Pract. 2017 Nov;133:1-9. doi: 10.1016/j.diabres.2017.07.033. Epub 2017 Aug 7. Review.

PMID:
28866383
2.

Subjective Estimation of Health Literacy-What Is Measured by the HLS-EU Scale and How Is It Linked to Empowerment?

Gerich J, Moosbrugger R.

Health Commun. 2018 Mar;33(3):254-263. doi: 10.1080/10410236.2016.1255846. Epub 2016 Dec 29.

PMID:
28033479
3.

Leaveism and illness-related behaviour.

Gerich J.

Occup Med (Lond). 2015 Dec;65(9):746-52. doi: 10.1093/occmed/kqv125. Epub 2015 Sep 25.

PMID:
26409053
4.

COMMENTARY ON FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED A1C.

Gerich JG.

Endocr Pract. 2015 Dec;21(12):1439-41. doi: 10.4158/EP15954.CO. Epub 2015 Aug 26. No abstract available.

PMID:
26307897
5.

Hypoglycemia in Patients with Diabetes and Renal Disease.

Alsahli M, Gerich JE.

J Clin Med. 2015 May 13;4(5):948-64. doi: 10.3390/jcm4050948. Review.

6.

Determinants of presenteeism prevalence and propensity: Two sides of the same coin?

Gerich J.

Arch Environ Occup Health. 2016 Jul 3;71(4):189-98. doi: 10.1080/19338244.2015.1011268. Epub 2015 Jan 28.

PMID:
25629640
7.

Hypoglycemia, chronic kidney disease, and diabetes mellitus.

Alsahli M, Gerich JE.

Mayo Clin Proc. 2014 Nov;89(11):1564-71. doi: 10.1016/j.mayocp.2014.07.013. Epub 2014 Oct 11. Review.

PMID:
25305751
8.

Sickness presence, sick leave and adjustment latitude.

Gerich J.

Int J Occup Med Environ Health. 2014 Oct;27(5):736-46. doi: 10.2478/s13382-014-0311-7. Epub 2014 Sep 24.

9.

Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.

Raccah D, Miossec P, Esposito V, Niemoeller E, Cho M, Gerich J.

Diabetes Metab Res Rev. 2015 Feb;31(2):204-11. doi: 10.1002/dmrr.2588. Epub 2014 Sep 16.

PMID:
25115916
10.

SGLT2 inhibitors in the treatment of type 2 diabetes.

Hasan FM, Alsahli M, Gerich JE.

Diabetes Res Clin Pract. 2014 Jun;104(3):297-322. doi: 10.1016/j.diabres.2014.02.014. Epub 2014 Mar 11. Review.

PMID:
24735709
11.

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies.

Gerich J.

Int J Gen Med. 2013 Dec 4;6:877-95. doi: 10.2147/IJGM.S51665. Review.

12.

Hypoglycemia.

Alsahli M, Gerich JE.

Endocrinol Metab Clin North Am. 2013 Dec;42(4):657-76. doi: 10.1016/j.ecl.2013.07.002. Review.

PMID:
24286945
13.

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).

Rosenstock J, Raccah D, Korányi L, Maffei L, Boka G, Miossec P, Gerich JE.

Diabetes Care. 2013 Oct;36(10):2945-51. doi: 10.2337/dc12-2709. Epub 2013 May 22.

14.

Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).

Fonseca VA, Alvarado-Ruiz R, Raccah D, Boka G, Miossec P, Gerich JE; EFC6018 GetGoal-Mono Study Investigators.

Diabetes Care. 2012 Jun;35(6):1225-31. doi: 10.2337/dc11-1935. Epub 2012 Mar 19.

15.

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with type 2 diabetes mellitus.

Gerich JE, Bastien A.

Expert Rev Clin Pharmacol. 2011 Nov;4(6):669-83. doi: 10.1586/ecp.11.54. Review.

PMID:
22111852
16.

Effects of social networks on the quality of life in an elder and middle-aged deaf community sample.

Gerich J, Fellinger J.

J Deaf Stud Deaf Educ. 2012 Winter;17(1):102-15. doi: 10.1093/deafed/enr022. Epub 2011 May 23.

PMID:
21606089
17.

Effect of hyperthyroidism on clearance and secretion of glucagon in man.

Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis AE, Gerich JE, Raptis SA.

Exp Clin Endocrinol Diabetes. 2011 Apr;119(4):214-7. doi: 10.1055/s-0030-1269880. Epub 2011 Jan 24.

PMID:
21264806
18.

DPP-4 inhibitors: what may be the clinical differentiators?

Gerich J.

Diabetes Res Clin Pract. 2010 Nov;90(2):131-40. doi: 10.1016/j.diabres.2010.07.006. Epub 2010 Aug 13. Review.

PMID:
20708812
19.

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.

Gerich JE.

Diabet Med. 2010 Feb;27(2):136-42. doi: 10.1111/j.1464-5491.2009.02894.x. Review.

20.

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.

Aryangat AV, Gerich JE.

Vasc Health Risk Manag. 2010 Mar 24;6:145-55. Review.

21.

Diabetes mellitus and gastric emptying: questions and issues in clinical practice.

Samsom M, Bharucha A, Gerich JE, Herrmann K, Limmer J, Linke R, Maggs D, Schirra J, Vella A, Wörle HJ, Göke B.

Diabetes Metab Res Rev. 2009 Sep;25(6):502-14. doi: 10.1002/dmrr.974. Review.

PMID:
19610128
22.

Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus.

Emerson P, Van Haeften TW, Pimenta W, Plummer E, Woerle HJ, Mitrakou A, Szoke E, Gerich J, Meyer C.

Metabolism. 2009 May;58(5):602-7. doi: 10.1016/j.metabol.2008.12.004.

23.

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L; LEAD-4 Study Investigators.

Diabetes Care. 2009 Jul;32(7):1224-30. doi: 10.2337/dc08-2124. Epub 2009 Mar 16. Erratum in: Diabetes Care. 2010 Mar;33(3):692.

24.

Is a history of gestational diabetes related to risk factors for coronary heart disease?

King KB, Gerich JE, Guzick DS, King KU, McDermott MP.

Res Nurs Health. 2009 Jun;32(3):298-306. doi: 10.1002/nur.20325.

PMID:
19274765
25.

Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide.

Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich JE, Göke B, Schirra J.

Diabetes Care. 2008 Dec;31(12):2325-31. doi: 10.2337/dc07-2446.

26.

Guideline for management of postmeal glucose.

Ceriello A, Colagiuri S, Gerich J, Tuomilehto J; Guideline Development Group.

Nutr Metab Cardiovasc Dis. 2008 May;18(4):S17-33. doi: 10.1016/j.numecd.2008.01.012. Review.

PMID:
18501571
27.

Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors.

Gerich JE.

Clin Cornerstone. 2007;8(3):53-68. Review.

PMID:
18452842
28.

Glycemic control in the metabolic syndrome and implications in preventing cardiovascular disease.

Gerich JE.

Metab Syndr Relat Disord. 2006 Winter;4(4):315-27. doi: 10.1089/met.2006.4.315.

PMID:
18370749
29.
30.

Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance.

Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, Mitrakou A, Pimenta W, Gerich JE.

Diabetes Care. 2008 Mar;31(3):539-43. Epub 2007 Dec 14.

PMID:
18083793
31.

Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans.

Woerle HJ, Albrecht M, Linke R, Zschau S, Neumann C, Nicolaus M, Gerich J, Göke B, Schirra J.

Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E103-9. Epub 2007 Oct 30.

32.

Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.

Gadegbeku CA, Dhandayuthapani A, Taylor TP, Shrayyef Z, Gerich J, Garvey WT, Egan BM.

J Am Soc Hypertens. 2007 Nov-Dec;1(6):414-22. doi: 10.1016/j.jash.2007.05.004.

PMID:
20409874
33.

Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naïve elderly patients with type 2 diabetes.

Schwarz SL, Gerich JE, Marcellari A, Jean-Louis L, Purkayastha D, Baron MA.

Diabetes Obes Metab. 2008 Aug;10(8):652-60. Epub 2007 Oct 15.

PMID:
17941876
34.
35.

Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease.

Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB.

J Thromb Haemost. 2007 May;5(5):942-9.

36.

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.

Dunning BE, Gerich JE.

Endocr Rev. 2007 May;28(3):253-83. Epub 2007 Apr 4. Review.

PMID:
17409288
37.

Mental distress and quality of life in the hard of hearing.

Fellinger J, Holzinger D, Gerich J, Goldberg D.

Acta Psychiatr Scand. 2007 Mar;115(3):243-5.

PMID:
17302625
38.

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.

PMID:
17240473
39.

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J.

Diabetes Care. 2006 Aug;29(8):1909-14.

PMID:
16873801
40.
41.

Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine.

Gerich J, Becker RH, Zhu R, Bolli GB.

Diabetes Technol Ther. 2006 Apr;8(2):237-43.

PMID:
16734552
42.

Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.

Israelian Z, Szoke E, Woerle J, Bokhari S, Schorr M, Schwenke DC, Cryer PE, Gerich JE, Meyer C.

Metabolism. 2006 May;55(5):593-8.

PMID:
16631434
43.

Postprandial hyperglycemia and cardiovascular disease.

Gerich JE.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:47-51. Review.

PMID:
16627380
44.

Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.

Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE.

Metabolism. 2006 Jan;55(1):78-83.

PMID:
16324923
45.

Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.

Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE, Meyer C.

Diabetes Care. 2005 Nov;28(11):2691-6.

PMID:
16249541
46.

The importance of tight glycemic control.

Gerich JE.

Am J Med. 2005 Sep;118(Suppl 9A):7S-11S. Review.

PMID:
16224937
47.

A potential important role of skeletal muscle in human counterregulation of hypoglycemia.

Meyer C, Saar P, Soydan N, Eckhard M, Bretzel RG, Gerich J, Linn T.

J Clin Endocrinol Metab. 2005 Nov;90(11):6244-50. Epub 2005 Sep 6. Erratum in: J Clin Endocrinol Metab. 2006 Jan;91(1):27.

PMID:
16144954
48.

Mental distress and quality of life in a deaf population.

Fellinger J, Holzinger D, Dobner U, Gerich J, Lehner R, Lenz G, Goldberg D.

Soc Psychiatry Psychiatr Epidemiol. 2005 Sep;40(9):737-42. Epub 2005 Sep 5.

PMID:
16143834
49.

PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.

Gerich J, Raskin P, Jean-Louis L, Purkayastha D, Baron MA.

Diabetes Care. 2005 Sep;28(9):2093-9.

PMID:
16123472
50.

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE.

Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E67-E77. Epub 2005 Aug 16.

Supplemental Content

Loading ...
Support Center